Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment
Diego Scheggia1,12, Rosa Mastrogiacomo1, Maddalena Mereu1,2, Sara Sannino1, Richard E. Straub3,
Marco Armando4, Francesca Managò1, Simone Guadagna1, Fabrizio Piras5, Fengyu Zhang3, Joel E. Kleinman3, Thomas M. Hyde3, Sanne S. Kaalund6, Maria Pontillo4, Genny Orso7, Carlo Caltagirone5, Emiliana Borrelli8, Maria A. De Luca9, Stefano Vicari4, Daniel R. Weinberger3,10, Gianfranco Spalletta5,11& Francesco Papaleo 1
Correction to:Nature Communicationshttps://doi.org/10.1038/s41467-018-04711-w, published online 11 Jun 2018.
In the original version of this Article, references in the Methods section incorrectly referred to references in the Supplementary References section. The relevant references (now numbered 20, 27, 42, 47, 69–80) have been removed from the Supplementary References section of the Supplementary Informationfile and added to the References section of the main manuscript, in both the PDF and HTML versions of the Article.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visithttp://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2018
DOI: 10.1038/s41467-018-06062-y OPEN
1Department of Neuroscience and Brain Technologies, Genetics of Cognition laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genova, Italy.
2Dipartimento di Scienze del Farmaco, Universita’ degli Studi di Padova, Largo Meneghetti 2, 35131 Padova, Italy.3Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, MD 21205, USA.4Department of Neuroscience, Bambino Gesù Children’s Hospital, Piazza Sant’Onofrio 4, 00100 Rome, Italy.5IRCCS Santa Lucia Foundation, Neuropsychiatry Laboratory, 00179 Rome, Italy.6Research Laboratory for Stereology and Neuroscience, Bispebjerg University Hospital, 2400 Copenhagen, NV, Denmark.7IRCCS E. Medea Scientific Institute, 23842 Bosisio Parini, Italy.
8University of California, Irvine, CA 92697, USA.9Department of Biomedical Sciences, Università di Cagliari, 09124 Cagliari, Italy.10Departments of Psychiatry, Neurology, Neuroscience and the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.11Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX 77030, USA.12Center for Psychiatric Neuroscience, Department of Psychiatry, University Hospital Center Lausanne, CH-, 1008 Prilly-Lausanne, Switzerland. Correspondence and requests for materials should be addressed to F.P. (email:francesco.papaleo@iit.it)
NATURE COMMUNICATIONS| (2018) 9:3560 | DOI: 10.1038/s41467-018-06062-y | www.nature.com/naturecommunications 1
1234567890():,;
